As CQDM enters a new phase of growth, the organization is evolving its governance model to support its ambitions and maximize its impact across Canada’s life sciences ecosystem.
In an environment where innovation depends on collaboration among researchers, entrepreneurs, companies, and institutional partners, effective governance must be representative, engaged, and closely connected to the realities of the sector. Recent changes to the composition of the Board of Directors reflect CQDM’s commitment to strengthening organizational leadership, expanding its pan-Canadian perspective, and further integrating scientific expertise into the strategic discussions that guide its development.
Through this evolution, CQDM reaffirms its commitment to advancing collaborative research and innovation in the life sciences for the benefit of patients, researchers, and businesses across Canada.
New Vice-Chair Position Created on the Board of Directors
To support this next stage of its evolution, CQDM’s Board of Directors has created a new Vice-Chair position.
CQDM is pleased to announce the appointment of Pierre Côté to this role. A member of the Board since 2023, Pierre brings extensive expertise and a deep understanding of Canada’s life sciences ecosystem.
His appointment as Vice-Chair is a natural extension of his ongoing commitment to the organization and will help strengthen the Board’s leadership as CQDM continues to grow and evolve. Drawing on his experience and strategic vision, he will support the Board’s work and help advance CQDM’s strategic priorities in the years ahead.
Enhanced Representation of Canada’s Life Sciences Ecosystem
CQDM is also welcoming two new Board members whose complementary expertise will enrich the organization’s strategic discussions.
Josh Pottel: Bringing an Entrepreneurial Perspective on AI-Powered Innovation
Co-Founder, President and CEO of Molecular Forecaster, Josh Pottel brings the perspective of an entrepreneur leading a growing Québec life sciences company at the intersection of artificial intelligence and drug discovery. Deeply engaged in Quebec and Canada’s life sciences ecosystems, he will bring to the Board valuable insights grounded in his understanding of the realities facing emerging companies, innovation and talent development.
Wendy Hurlburt: Pan-Canadian Expertise in Ecosystem Development
President and CEO of Life Sciences BC, Wendy Hurlburt plays a leading role in advancing and raising the profile of British Columbia’s life sciences ecosystem by fostering connections among companies, research institutions, governments and international partners. Her diverse experience spanning life sciences, technology, finance and business development will bring valuable perspective to the Board and strengthen its pan-Canadian outlook.
Jennifer Hamilton Appointed Honorary Member of the Board of Directors
This announcement also marks the formal appointment of Jennifer Hamilton as an Honorary Member of the Board of Directors.
As Chair of CQDM’s Scientific Advisory Committee, she already plays a central role in assessing the scientific excellence, strategic relevance, and innovation potential of the projects supported by the organization.
Her participation on the Board will help ensure stronger integration of scientific perspectives into strategic discussions while deepening the connection between the Scientific Advisory Committee and the Board of Directors.
Representative Governance with a Forward-Looking Vision
According to Richard Fajzel, Chair of CQDM’s Board of Directors, these changes reflect a clear commitment to ensuring the organization continues to meet the evolving needs of the sector:
“Strong governance is built on diverse perspectives and a deep understanding of the ecosystem it serves. These changes reflect CQDM’s continued evolution and our ambition to build a governance model that is representative, engaged and equipped to support the organization’s next stage of growth.”
Governance in Support of Health Innovation
By bringing together complementary scientific, entrepreneurial, and organizational expertise, CQDM continues to advance its mission of supporting collaborative innovation in the life sciences.
These appointments will strengthen the organization’s ability to support companies, researchers, and ecosystem partners in developing the innovations that will shape the future of healthcare.
FAQ
CQDM is adapting its governance model to better reflect the evolution of Canada’s life sciences ecosystem and to strengthen its ability to support health innovation.
CQDM welcomes Josh Pottel, Co-Founder and CEO of Molecular Forecaster, and Wendy Hurlburt, President and CEO of Life Sciences BC, to its Board of Directors. Pierre Côté has also been appointed to the newly created role of Vice-Chair of the Board.
The Board of Directors helps define the organization’s strategic direction, ensures sound governance, and oversees CQDM’s mission to support innovation in the life sciences sector.
Jennifer Hamilton is Chair of CQDM’s Scientific Advisory Committee. She has been appointed Honorary Member of the Board of Directors to strengthen the integration of scientific perspectives into the organization’s strategic decision-making.